The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Trial of AK104 Plus Anlotinib in NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epidemiology of Young Lung Cancer - Survey
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate D-1553 in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
- Status
- UNKNOWN
- Phase
- N/A
An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network
- Status
- COMPLETED
- Phase
- N/A
Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients
- Status
- COMPLETED
- Phase
- NA
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor
- Status
- COMPLETED
- Phase
- N/A
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
- Status
- RECRUITING
- Phase
- N/A
Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
- Status
- UNKNOWN
- Phase
- N/A